Skip to main content
. 2020 Nov 18;8(1):ofaa561. doi: 10.1093/ofid/ofaa561

Table 2.

Prevalence of Sleep Disordersa

Sleep Disorder Older PWH (n = 219) Younger PWH (n = 102) Older HIV, Controls (n = 118)
Insomnia (ISI ≥15) 46 (21.0%) 23 (22.6%) 6 (5.1%)
 Medical history 10/46 (21.7%) 7/23 (30.4%) 1/6 (16.7%)
 Treatment history 9/46 (19.6%) 6/23 (26.1%) 1/6 (16.7%)
Restless Legs Syndrome (3 of 3 cardinal symptoms on IRLSSG questionnaire) 34 (15.5%) 8 (7.8%) 17 (14.4%)
 Medical history 1/34 (2.9%) 0/8 (0.0%) 2/17 (11.8%)
 Treatment history 0/34 (0.0%) 0/8 (0.0%) 2/17 (11.8%)
Sleep Apnea (ODI ≥5/hour) 16 (7.3%) 4 (3.9%) 9 (7.6%)
 Medical history 0/16 (0.0%) 0/4 (0.0%) 1/9 (11.1%)
 Treatment history 0/16 (0.0%) 0/4 (0.0%) 0/9 (0.0%)
Number of Sleep Disordersb
 0 138 (63.0%) 69 (67.6%) 91 (77.1%)
 1 66 (30.1%) 31 (30.4%) 22 (18.6%)
 2+ 15 (6.9%) 2 (2.0%) 5 (4.2%)

Abbreviations: HIV, human immunodeficiency virus; IRLSSG, International Restless Legs Syndrome Study Group; ISI, Insomnia Severity Index; ODI, oxygen desaturation index; PWH, persons with HIV.

aProportions of study participants meeting criteria for insomnia (by Insomnia Severity Index [ISI] questionnaire ≥15), restless legs syndrome (by reporting 3 of 3 cardinal symptoms on International Restless Legs Syndrome Study Group [IRLSSG] questionnaire), and sleep apnea (by overnight oximetry testing ODI ≥5/hour), along with distribution of those meeting criteria for zero, 1, or at least 2 sleep disorders. Also shown are participant-reported medical history of previous diagnoses and self-reported current or previous treatment, among those meeting criteria for the sleep disorder.

bSee Supplemental Figure for further details of overlapping sleep disorders.